Age, Neuropathology, and Dementia
Open accessThe DOI matches its Crossref record; 33 of the 34 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Research in Alzheimer's disease is focused mainly on younger old persons, whereas studies involving very old persons report attenuated relationships between the pathological features of Alzheimer's disease and dementia. METHODS: We assessed 456 brains donated to the population-based Medical Research Council Cognitive Function and Ageing Study from persons 69 to 103 years of age at death. We used a standard neuropathological protocol that included measures of the pathological features of Alzheimer's disease, cerebral atrophy, and cerebrovascular disease. Neuropathological variables were dichotomized to represent no burden or a mild burden of pathological lesions as compared with a moderate or severe burden. Logistic regression was used to estimate the effect of age on the relationship between neuropathological features and dementia. RESULTS: The difference in the prevalence of moderate and severe Alzheimer's-type pathological changes between persons with and those without dementia decreased with increasing age. The association between neocortical neuritic plaques and dementia was strong at 75 years of age (odds ratio, 8.63; 95% confidence interval [CI], 3.81 to 19.60) and reduced at 95 years of age (odds ratio, 2.48; 95% CI, 0.92 to 4.14), and similar attenuations with advancing age were observed in the association between other pathological changes related to Alzheimer's disease and dementia in all brain areas. In contrast, neocortical cerebral atrophy maintained a relationship with age in persons with dementia at both 75 years of age (odds ratio, 5.11; 95% CI, 1.94 to 13.46) and 95 years of age (odds ratio, 6.10; 95% CI, 2.80 to 13.28) and thus distinguished the cohort with dementia from the cohort without dementia. CONCLUSIONS: The association between the pathological features of Alzheimer's disease and dementia is stronger in younger old persons than in older old persons. Age must be taken into account when assessing the likely effect of interventions against dementia on the population.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“loss of growth factors, such as the brain-derived neurotrophic factor,96 may contribute to the brain atrophy associated with Alzheimer disease and VCI.134,135”
In the citing paper
“The Baltimore Longitudinal Study of Aging (O’Brien, et al., 2009), the Honolulu-Asia Aging Study (White, 2009), and the MRC-CFAS (Savva, et al., 2009) have similarly reported dissociations between plaques, tangles or other pathological lesions and cognition.”
From Cellular, synaptic, and biochemical features of resilient cognition in Alzheimer’s disease (2013) · cites this paper as Savva, et al., 2009
In the citing paper
“Autopsy studies reveal at the time of death, brains from cognitively normal individuals frequently contain plaques [77, 234-237].”
From The Alzheimer’s disease mitochondrial cascade hypothesis: progress and perspectives (2014) · cites this paper as [235]
In the citing paper
“Frequently, however, alternative pathologies are also seen in demented patients with plaques and tangles [50–52].”
From Brain aging, Alzheimer's disease, and mitochondria (2011) · cites this paper as [51]
In the citing paper
“Decades of clinical-pathological correlative studies, now corroborated by a decade of neuroimaging studies, also demonstrate a sizable percentage of the non-demented elderly have plaques [40, 51, 54, 55, 58–68].”
From Brain aging, Alzheimer's disease, and mitochondria (2011) · cites this paper as [51]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
Global prevalence of dementia: a Delphi consensus study
Ferri, C. P., Prince, M., Brayne, C., Brodaty, H., Fratiglioni, L., Ganguli, M., Hall, K., Hasegawa, K., Hendrie, H., Huang, Y., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67889-0 · Cited by 5,332
Self-citationTerry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397
Observations on the brains of demented old people
Tomlinson, B. E., Blessed, G., & Roth, M. (1970) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(70)90063-8 · Cited by 2,084
Mixed brain pathologies account for most dementia cases in community-dwelling older persons
Schneider, J. A., Arvanitakis, Z., Bang, W., & Bennett, D. A. (2007) · Neurology · doi:10.1212/01.wnl.0000271090.28148.24 · Cited by 1,992
Hachinski, V., Iadecola, C., Petersen, R. C., Breteler, M. M., Nyenhuis, D. L., Black, S. E., Powers, W. J., DeCarli, C., Merino, J. G., Kalaria, R. N., et al. (2006) · Stroke · doi:10.1161/01.str.0000237236.88823.47 · Cited by 1,722
Frequency of Stages of Alzheimer-Related Lesions in Different Age Categories
Braak, H., & Braak, E. (1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(97)00056-0 · Cited by 1,656
(2001) · The Lancet · doi:10.1016/s0140-6736(00)03589-3 · Cited by 1,338
Neuropathology of older persons without cognitive impairment from two community-based studies
Bennett, D. A., Schneider, J. A., Arvanitakis, Z., Kelly, J. F., Aggarwal, N. T., Shah, R. C., & Wilson, R. S. (2006) · Neurology · doi:10.1212/01.wnl.0000219668.47116.e6 · Cited by 1,336
MULTI-INFARCT DEMENTIA A CAUSE OF MENTAL DETERIORATION IN THE ELDERLY
HACHINSKI, V (1974) · The Lancet · doi:10.1016/s0140-6736(74)91496-2 · Cited by 1,093
Research works printed but not linked: 1
- Fratiglioni L, 2000, Neurology, 54, S10
Cited by
Items 101–200 of 920
Brayne, C., the Cambridge City over-75s Cohort (CC75C) study neuropathology collaboration, Richardson, K., Matthews, F. E., Fleming, J., Hunter, S., Xuereb, J. H., Paykel, E., Mukaetova-Ladinska, E. B., Huppert, F. A., et al. (2009) · Journal of Alzheimer's Disease · doi:10.3233/jad-2009-1182 · Cited by 191
Self-citationCerebral dysfunctions caused by sepsis during ageing
Manabe, T., & Heneka, M. T. (2022) · Nature Reviews Immunology · doi:10.1038/s41577-021-00643-7 · Cited by 191
The Epigenome and Nature/Nurture Reunification: A Challenge for Anthropology
Lock, M. (2013) · Medical Anthropology · doi:10.1080/01459740.2012.746973 · Cited by 180
PARK2 enhancement is able to compensate mitophagy alterations found in sporadic Alzheimer's disease
Martín-Maestro, P., Gargini, R., Perry, G., Avila, J., & García-Escudero, V. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddv616 · Cited by 184
Late-onset vs nonmendelian early-onset Alzheimer disease: A distinction without a difference?
Reitz, C., Rogaeva, E., & Beecham, G. W. (2020) · Neurology Genetics · doi:10.1212/nxg.0000000000000512 · Cited by 168
Epidemiology of neurological diseases in older adults
Dumurgier, J., & Tzourio, C. (2020) · Revue Neurologique · doi:10.1016/j.neurol.2020.01.356 · Cited by 167
Neuropathological correlates of late-life depression in older people
Tsopelas, C., Stewart, R., Savva, G. M., Brayne, C., Ince, P., Thomas, A., & Matthews, F. E. (2011) · British Journal of Psychiatry · doi:10.1192/bjp.bp.110.078816 · Cited by 182
“18,21,25 The neuropathological assessment was a standardised assessment of paraffin-embedded tissues using the CERAD protocol.”
Self-citationAge-related Hearing Loss and Dementia
Chern, A., & Golub, J. S. (2019) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0000000000000325 · Cited by 165
Concomitant vascular and neurodegenerative pathologies double the risk of dementia
Azarpazhooh, M. R., Avan, A., Cipriano, L. E., Munoz, D. G., Sposato, L. A., & Hachinski, V. (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2017.07.755 · Cited by 175
Population based study on patients with traumatic brain injury suggests increased risk of dementia
Wang, H.-K., Lin, S.-H., Sung, P.-S., Wu, M.-H., Hung, K.-W., Wang, L.-C., Huang, C.-Y., Lu, K., Chen, H.-J., & Tsai, K.-J. (2012) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2012-302633 · Cited by 179
Pathological combinations in neurodegenerative disease are heterogeneous and disease-associated
Robinson, J. L., Xie, S. X., Baer, D. R., Suh, E., Van Deerlin, V. M., Loh, N. J., Irwin, D. J., McMillan, C. T., Wolk, D. A., Chen-Plotkin, A., et al. (2023) · Brain · doi:10.1093/brain/awad059 · Cited by 176
Schwarz, C. G., Reid, R. I., Gunter, J. L., Senjem, M. L., Przybelski, S. A., Zuk, S. M., Whitwell, J. L., Vemuri, P., Josephs, K. A., Kantarci, K., et al. (2014) · NeuroImage · doi:10.1016/j.neuroimage.2014.03.026 · Cited by 171
Age and diagnostic performance of Alzheimer disease CSF biomarkers
Mattsson, N., Rosén, E., Hansson, O., Andreasen, N., Parnetti, L., Jonsson, M., Herukka, S.-K., van der Flier, W. M., Blankenstein, M. A., Ewers, M., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e3182477eed · Cited by 171
Update on the Pharmacological Treatment of Alzheimers Disease
Massoud, F., & Gauthier, S. (2010) · Current Neuropharmacology · doi:10.2174/157015910790909520 · Cited by 163
Are Empirically-Derived Subtypes of Mild Cognitive Impairment Consistent with Conventional Subtypes?
Clark, L. R., Delano-Wood, L., Libon, D. J., McDonald, C. R., Nation, D. A., Bangen, K. J., Jak, A. J., Au, R., Salmon, D. P., & Bondi, M. W. (2013) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617713000313 · Cited by 167
Odor identification and Alzheimer disease biomarkers in clinically normal elderly
Growdon, M. E., Schultz, A. P., Dagley, A. S., Amariglio, R. E., Hedden, T., Rentz, D. M., Johnson, K. A., Sperling, R. A., Albers, M. W., & Marshall, G. A. (2015) · Neurology · doi:10.1212/wnl.0000000000001614 · Cited by 160
Non-Alzheimer’s contributions to dementia and cognitive resilience in The 90+ Study
Robinson, J. L., Corrada, M. M., Kovacs, G. G., Dominique, M., Caswell, C., Xie, S. X., Lee, V. M.-Y., Kawas, C. H., & Trojanowski, J. Q. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1872-5 · Cited by 162
Rutjes, A. W., Denton, D. A., Di Nisio, M., Chong, L.-Y., Abraham, R. P., Al-Assaf, A. S., Anderson, J. L., Malik, M. A., Vernooij, R. W., Martínez, G., et al. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011906.pub2 · Cited by 164
A Population-Based Clinicopathological Study in the Oldest-Old: The 90+ Study
M. Corrada, M., J. Berlau, D., & H. Kawas, C. (2012) · Current Alzheimer Research · doi:10.2174/156720512801322537 · Cited by 162
“Most studies have noted that the association between AD pathology and dementia is weaker in older elderly compared with younger elderly [27, 28].”
BackgroundMcCleery, J., Abraham, R. P., Denton, D. A., Rutjes, A. W., Chong, L.-Y., Al-Assaf, A. S., Griffith, D. J., Rafeeq, S., Yaman, H., Malik, M. A., et al. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011905.pub2 · Cited by 162
“However, the proportion of dementia attributable to Alzheimer’s disease reduces with age (Savva 2009).”
BackgroundCerebrospinal fluid biomarkers in trials for Alzheimer and Parkinson diseases
Lleó, A., Cavedo, E., Parnetti, L., Vanderstichele, H., Herukka, S. K., Andreasen, N., Ghidoni, R., Lewczuk, P., Jeromin, A., Winblad, B., et al. (2015) · Nature Reviews Neurology · doi:10.1038/nrneurol.2014.232 · Cited by 159
“New Old Pathologies”: AD, PART, and Cerebral Age-Related TDP-43 With Sclerosis (CARTS)
Nelson, P. T., Trojanowski, J. Q., Abner, E. L., Al-Janabi, O. M., Jicha, G. A., Schmitt, F. A., Smith, C. D., Fardo, D. W., Wang, W.-X., Kryscio, R. J., et al. (2016) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlw033 · Cited by 158
Weidenheim, K. M., Dickson, D. W., & Rapin, I. (2009) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2009.07.006 · Cited by 156
Immunohistological detection of Chlamydia pneumoniae in the Alzheimer's disease brain
Hammond, C. J., Hallock, L. R., Howanski, R. J., Appelt, D. M., Little, C. S., & Balin, B. J. (2010) · BMC Neuroscience · doi:10.1186/1471-2202-11-121 · Cited by 156
“Notably, histopathological amyloid plaques and tangles are used to define the stage of AD, but the correlation with the pathology of the disease and the clinical manifestations of the disease are not always clear [ 2 ].”
BackgroundWahl, D., Solon-Biet, S. M., Cogger, V. C., Fontana, L., Simpson, S. J., Le Couteur, D. G., & Ribeiro, R. V. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104481 · Cited by 144
Challenges of multimorbidity of the aging brain: a critical update
Jellinger, K. A., & Attems, J. (2015) · Journal of Neural Transmission · doi:10.1007/s00702-014-1288-x · Cited by 154
Cognition, glucose metabolism and amyloid burden in Alzheimer's disease
Furst, A. J., Rabinovici, G. D., Rostomian, A. H., Steed, T., Alkalay, A., Racine, C., Miller, B. L., & Jagust, W. J. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.03.011 · Cited by 144
Amyloid and tau proteins in cortical brain biopsy and Alzheimer's disease
Leinonen, V., Koivisto, A. M., Savolainen, S., Rummukainen, J., Tamminen, J. N., Tillgren, T., Vainikka, S., Pyykkö, O. T., Mölsä, J., Fraunberg, M., et al. (2010) · Annals of Neurology · doi:10.1002/ana.22100 · Cited by 150
Scuteri, A., Nilsson, P. M., Tzourio, C., Redon, J., & Laurent, S. (2011) · Journal of Hypertension · doi:10.1097/hjh.0b013e328347cc17 · Cited by 151
Mormino, E. C., Brandel, M. G., Madison, C. M., Marks, S., Baker, S. L., & Jagust, W. J. (2012) · Cerebral Cortex · doi:10.1093/cercor/bhr255 · Cited by 153
Thambisetty, M., An, Y., Kinsey, A., Koka, D., Saleem, M., Gϋntert, A., Kraut, M., Ferrucci, L., Davatzikos, C., Lovestone, S., et al. (2012) · NeuroImage · doi:10.1016/j.neuroimage.2011.07.056 · Cited by 148
Li, W., Yu, J., Liu, Y., Huang, X., Abumaria, N., Zhu, Y., Huang, X., Xiong, W., Ren, C., Liu, X.-G., et al. (2014) · Molecular Brain · doi:10.1186/s13041-014-0065-y · Cited by 146
Increased brain atrophy rates in cognitively normal older adults with low cerebrospinal fluid Aβ1‐42
Schott, J. M., Bartlett, J. W., Fox, N. C., Barnes, J., & for the Alzheimer's Disease Neuroimaging Initiative Investigators (2010) · Annals of Neurology · doi:10.1002/ana.22315 · Cited by 151
Sleep disturbances and dementia risk: a multicenter study
Sindi, S., Kåreholt, I., Johansson, L., Skoog, J., Sjöberg, L., Wang, H., Johansson, B., Fratiglioni, L., Soininen, H., Solomon, A., et al. (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.05.012 · Cited by 144
New landscape of the diagnosis of Alzheimer’s disease
Frisoni, G. B., Hansson, O., Nichols, E., Garibotto, V., Schindler, S. E., van der Flier, W. M., Jessen, F., Villain, N., Arenaza-Urquijo, E. M., Crivelli, L., et al. (2025) · The Lancet · doi:10.1016/s0140-6736(25)01294-2 · Cited by 143
Mattsson, N., Lönneborg, A., Boccardi, M., Blennow, K., & Hansson, O. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.02.034 · Cited by 129
Akyol, S., Ugur, Z., Yilmaz, A., Ustun, I., Gorti, S. K. K., Oh, K., McGuinness, B., Passmore, P., Kehoe, P. G., Maddens, M. E., et al. (2021) · Cells · doi:10.3390/cells10102591 · Cited by 134
Cerebral amyloid PET imaging in Alzheimer’s disease
Jack, C. R., Barrio, J. R., & Kepe, V. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1185-7 · Cited by 121
Harrison, J. K., Fearon, P., Noel-Storr, A. H., McShane, R., Stott, D. J., & Quinn, T. J. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010772.pub2 · Cited by 128
TDP-43 pathology and memory impairment in elders without pathologic diagnoses of AD or FTLD
Nag, S., Yu, L., Wilson, R. S., Chen, E.-Y., Bennett, D. A., & Schneider, J. A. (2017) · Neurology · doi:10.1212/wnl.0000000000003610 · Cited by 130
Sabuncu, M. R., Buckner, R. L., Smoller, J. W., Lee, P. H., Fischl, B., & Sperling, R. A. (2012) · Cerebral Cortex · doi:10.1093/cercor/bhr348 · Cited by 133
Esposito, R., Cieri, F., Chiacchiaretta, P., Cera, N., Lauriola, M., Giannantonio, M. D., Tartaro, A., & Ferretti, A. (2017) · Brain Imaging and Behavior · doi:10.1007/s11682-017-9686-y · Cited by 145
When Does Alzheimer′s Disease Really Start? The Role of Biomarkers
Lloret, A., Esteve, D., Lloret, M.-A., Cervera-Ferri, A., Lopez, B., Nepomuceno, M., & Monllor, P. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20225536 · Cited by 131
Liang, K. J., & Carlson, E. S. (2019) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2019.01.004 · Cited by 143
Pharmacological Treatment of Alzheimer Disease
Massoud, F., & Léger, G. C. (2011) · The Canadian Journal of Psychiatry · doi:10.1177/070674371105601003 · Cited by 120
Plasma homocysteine, Alzheimer and cerebrovascular pathology: a population-based autopsy study
Hooshmand, B., Polvikoski, T. M., Kivipelto, M., Tanskanen, M., Myllykangas, L., Erkinjuntti, T., Mäkelä, M., Oinas, M., Paetau, A. E., Scheltens, P., et al. (2013) · Brain · doi:10.1093/brain/awt206 · Cited by 135
Ossenkoppele, R., Reimand, J., Smith, R., Leuzy, A., Strandberg, O., Palmqvist, S., Stomrud, E., Zetterberg, H., Initiative, T. A. D. N., Scheltens, P., et al. (2021) · EMBO Molecular Medicine · doi:10.15252/emmm.202114398 · Cited by 130
Epidemiological Neuropathology: The MRC Cognitive Function and Aging Study Experience
Wharton, S. B., on behalf of the Medical Research Council Cognitive Function and Aging Study, Brayne, C., Savva, G. M., Matthews, F. E., Forster, G., Simpson, J., Lace, G., & Ince, P. G. (2011) · Journal of Alzheimer's Disease · doi:10.3233/jad-2011-091402 · Cited by 124
Self-citationSmallwood, A., Oulhaj, A., Joachim, C., Christie, S., Sloan, C., Smith, A. D., & Esiri, M. (2012) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2011.01221.x · Cited by 127
Sex and age interact to determine clinicopathologic differences in Alzheimer’s disease
Liesinger, A. M., Graff-Radford, N. R., Duara, R., Carter, R. E., Hanna Al-Shaikh, F. S., Koga, S., Hinkle, K. M., DiLello, S. K., Johnson, M. F., Aziz, A., et al. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1908-x · Cited by 126
Clinical and imaging features of mixed Alzheimer and vascular pathologies
Chui, H. C., & Ramirez-Gomez, L. (2015) · Alzheimer's Research & Therapy · doi:10.1186/s13195-015-0104-7 · Cited by 124
Cellular, synaptic, and biochemical features of resilient cognition in Alzheimer’s disease
Arnold, S. E., Louneva, N., Cao, K., Wang, L.-S., Han, L.-Y., Wolk, D. A., Negash, S., Leurgans, S. E., Schneider, J. A., Buchman, A. S., et al. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.03.004 · Cited by 123
“, 2009), the Honolulu-Asia Aging Study (White, 2009), and the Medical Research Council Cognitive Function and Ageing Study (Savva et al., 2009) have similarly reported dissociations”
MethodQuinn, T. J., Fearon, P., Noel-Storr, A. H., Young, C., McShane, R., & Stott, D. J. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010079.pub2 · Cited by 116
PPARs in the central nervous system: roles in neurodegeneration and neuroinflammation
Zolezzi, J. M., Santos, M. J., Bastías‐Candia, S., Pinto, C., Godoy, J. A., & Inestrosa, N. C. (2017) · Biological Reviews · doi:10.1111/brv.12320 · Cited by 122
Validity, Reliability, and Feasibility of Clinical Staging Scales in Dementia: A Systematic Review
Olde Rikkert, M. G. M., Tona, K. D., Janssen, L., Burns, A., Lobo, A., Robert, P., Sartorius, N., Stoppe, G., & Waldemar, G. (2011) · American Journal of Alzheimer's Disease & Other Dementias® · doi:10.1177/1533317511418954 · Cited by 120
Vascular Risk Factors: Imaging and Neuropathologic Correlates
Knopman, D. S., & Roberts, R. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-091555 · Cited by 124
Richard, E., Andrieu, S., Solomon, A., Mangialasche, F., Ahtiluoto, S., van Charante, E. P. M., Coley, N., Fratiglioni, L., Neely, A. S., Vellas, B., et al. (2012) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2012.06.012 · Cited by 121
“vascular involvement [3,4].”
Deconstructing Mitochondrial Dysfunction in Alzheimer Disease
García-Escudero, V., Martín-Maestro, P., Perry, G., & Avila, J. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/162152 · Cited by 119
Alzheimer’s disease CSF biomarkers: clinical indications and rational use
Niemantsverdriet, E., Valckx, S., Bjerke, M., & Engelborghs, S. (2017) · Acta Neurologica Belgica · doi:10.1007/s13760-017-0816-5 · Cited by 114
Landeiro, F., Mughal, S., Walsh, K., Nye, E., Morton, J., Williams, H. M., Ghinai, I., Castro, Y., Leal, J., Roberts, N. W., et al. (2020) · Alzheimer s Research & Therapy · doi:10.1186/s13195-020-00723-1 · Cited by 127
Endothelial Dysfunction and Amyloid-β-Induced Neurovascular Alterations
Koizumi, K., Wang, G., & Park, L. (2016) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-015-0256-9 · Cited by 118
Is synaptic loss a unique hallmark of Alzheimer’s disease?
Scheff, S. W., Neltner, J. H., & Nelson, P. T. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.12.028 · Cited by 118
Aguilar, C., Westman, E., Muehlboeck, J., Mecocci, P., Vellas, B. J., Tsolaki, M., Kłoszewska, I., Soininen, H. S., Lovestone, S., Spenger, C., et al. (2013) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2012.11.005 · Cited by 127
Efficacy and safety of medical cannabinoids in older subjects: A systematic review
van den Elsen, G. A. H., Ahmed, A. I. A., Lammers, M. W., Kramers, C., Verkes, R., van der Marck, M. A., & Rikkert, M. G. M. O. (2014) · Ageing Research Reviews · doi:10.1016/j.arr.2014.01.007 · Cited by 130
Dementia and mild cognitive impairment in adults with intellectual disability: Issues of diagnosis
Krinsky‐McHale, S. J., & Silverman, W. (2013) · Developmental Disabilities Research Reviews · doi:10.1002/ddrr.1126 · Cited by 108
Alzheimer's disease outlook: controversies and future directions
Frisoni, G. B., Aho, E., Brayne, C., Ciccarelli, O., Dubois, B., Fox, N. C., Frederiksen, K. S., Gabay, C., Garibotto, V., Hofmarcher, T., et al. (2025) · The Lancet · doi:10.1016/s0140-6736(25)01389-3 · Cited by 135
Self-citationThe metabolic brain signature of cognitive resilience in the 80+: beyond Alzheimer pathologies
Arenaza-Urquijo, E. M., Przybelski, S. A., Lesnick, T. L., Graff-Radford, J., Machulda, M. M., Knopman, D. S., Schwarz, C. G., Lowe, V. J., Mielke, M. M., Petersen, R. C., et al. (2019) · Brain · doi:10.1093/brain/awz037 · Cited by 110
Dementia in the oldest old: a multi-factorial and growing public health issue
Gardner, R. C., Valcour, V., & Yaffe, K. (2013) · Alzheimer's Research & Therapy · doi:10.1186/alzrt181 · Cited by 108
Chronic kidney disease is associated with dementia independent of cerebral small-vessel disease
Miwa, K., Tanaka, M., Okazaki, S., Furukado, S., Yagita, Y., Sakaguchi, M., Mochizuki, H., & Kitagawa, K. (2014) · Neurology · doi:10.1212/wnl.0000000000000251 · Cited by 114
Petersen, C., Nolan, A. L., de Paula França Resende, E., Miller, Z., Ehrenberg, A. J., Gorno-Tempini, M. L., Rosen, H. J., Kramer, J. H., Spina, S., Rabinovici, G. D., et al. (2019) · Acta Neuropathologica · doi:10.1007/s00401-019-02036-6 · Cited by 113
Tosun, D., Landau, S., Aisen, P. S., Petersen, R. C., Mintun, M., Jagust, W., Weiner, M. W., & Initiative, F. T. A. D. N. (2017) · Brain · doi:10.1093/brain/awx046 · Cited by 107
Davis, D. H. J., Creavin, S., Noel-Storr, A., Quinn, T. J., Smailagic, N., Hyde, C., Brayne, C., McShane, R. H., & Cullum, S. J. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010460 · Cited by 112
Self-citationJicha, G. A., & Carr, S. A. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-1237 · Cited by 102
Pyroglutamate Abeta pathology in APP/PS1KI mice, sporadic and familial Alzheimer’s disease cases
Wirths, O., Bethge, T., Marcello, A., Harmeier, A., Jawhar, S., Lucassen, P. J., Multhaup, G., Brody, D. L., Esparza, T., Ingelsson, M., et al. (2010) · Journal of Neural Transmission · doi:10.1007/s00702-009-0314-x · Cited by 106
“Most recently, it has been shown that plaque load in non-demented individuals constantly increases with aging, while it decreases in AD patients older than 95 years (Savva et al. 2009).”
BackgroundBeyond the average patient: how neuroimaging models can address heterogeneity in dementia
Verdi, S., Marquand, A. F., Schott, J. M., & Cole, J. H. (2021) · Brain · doi:10.1093/brain/awab165 · Cited by 106
The aging brain and cognition: contribution of vascular injury and aβ to mild cognitive dysfunction
Marchant, N. L., Reed, B. R., Sanossian, N., Madison, C. M., Kriger, S., Dhada, R., Mack, W. J., DeCarli, C., Weiner, M. W., Mungas, D. M., et al. (2013) · JAMA Neurology · doi:10.1001/2013.jamaneurol.405 · Cited by 106
Brain pathologies in extreme old age
Neltner, J. H., Abner, E. L., Jicha, G. A., Schmitt, F. A., Patel, E., Poon, L. W., Marla, G., Green, R. C., Davey, A., Johnson, M. A., et al. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.10.009 · Cited by 106
Rates of Decline in Alzheimer Disease Decrease with Age
Holland, D., Desikan, R. S., Dale, A. M., McEvoy, L. K., & Initiative, F. T. A. D. N. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042325 · Cited by 99
Entorhinal cortex tau, amyloid-β, cortical thickness and memory performance in non-demented subjects
Knopman, D. S., Lundt, E. S., Therneau, T. M., Vemuri, P., Lowe, V. J., Kantarci, K., Gunter, J. L., Senjem, M. L., Mielke, M. M., Machulda, M. M., et al. (2019) · Brain · doi:10.1093/brain/awz025 · Cited by 97
Garcez, M. L., Mina, F., Bellettini-Santos, T., Carneiro, F. G., Luz, A. P., Schiavo, G. L., Andrighetti, M. S., Scheid, M. G., Bolfe, R. P., & Budni, J. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.03.010 · Cited by 102
Balasubramanian, A. B., Kawas, C. H., Peltz, C. B., Brookmeyer, R., & Corrada, M. M. (2012) · Neurology · doi:10.1212/wnl.0b013e318266fc77 · Cited by 99
Dementia in Patients Hospitalized with Stroke: Rates, Time Course, and Clinico-Pathologic Factors
Pendlebury, S. T. (2012) · International Journal of Stroke · doi:10.1111/j.1747-4949.2012.00837.x · Cited by 97
Neuroinflammation in Alzheimer’s disease wanes with age
Hoozemans, J. J., Rozemuller, A. J., van Haastert, E. S., Eikelenboom, P., & van Gool, W. A. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-171 · Cited by 100
“implies that the diagnostic value of biomarkers related to the underlying biological process leading to accumulation of tangles or plaques is much more prominent in the relatively young compared with the oldest patients, and indicates that the pathological substrate that causes dementia is heterogeneous and age-depend…”
BackgroundResultMultiple Biological Pathways Link Cognitive Lifestyle to Protection from Dementia
Valenzuela, M. J., Matthews, F. E., Brayne, C., Ince, P., Halliday, G., Kril, J. J., Dalton, M. A., Richardson, K., Forster, G., & Sachdev, P. S. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.07.036 · Cited by 100
Self-citationCognitive reserve, presynaptic proteins, and dementia in the elderly
Honer, W. G., Barr, A. M., Sawada, K., Thornton, A. E., Morris, M. C., Leurgans, S. E., Schneider, J. A., & Bennett, D. A. (2012) · Translational Psychiatry · doi:10.1038/tp.2012.38 · Cited by 100
The Alzheimer's Disease Neuroimaging Initiative 2 Biomarker Core: A review of progress and plans
Kang, J., Korecka, M., Figurski, M. J., Toledo, J. B., Blennow, K., Zetterberg, H., Waligorska, T., Brylska, M., Fields, L., Shah, N., et al. (2015) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2015.05.003 · Cited by 99
Ligthart, S., Richard, E., van Charante, M., & Gool, V. (2010) · Vascular Health and Risk Management · doi:10.2147/vhrm.s7343 · Cited by 96
Amyloid PET in clinical practice: Its place in the multidimensional space of Alzheimer's disease
Vandenberghe, R., Adamczuk, K., Dupont, P., Laere, K. V., & Chételat, G. (2013) · NeuroImage: Clinical · doi:10.1016/j.nicl.2013.03.014 · Cited by 99
“In a prospective population-based series of 456 autopsy cases between 70 and 100 years of age (Savva et al., 2009), a strong relationship between dementia and the presence of NFT and neuritic plaqueswas seen until 75 years of age (Savva et al., 2009).”
BackgroundMethodInfluentialSilva, A. R. T., Santos, A. C. F., Farfel, J. M., Grinberg, L. T., Ferretti, R. E. L., Campos, A. H. J. F. M., Cunha, I. W., Begnami, M. D., Rocha, R. M., Carraro, D. M., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0099897 · Cited by 99
“In addition, more recent large-scale epidemiological studies have shown discordance of cognition with AD pathology [16–20].”
BackgroundMulticolor time-stamp reveals the dynamics and toxicity of amyloid deposition
Condello, C., Schain, A., & Grutzendler, J. (2011) · Scientific Reports · doi:10.1038/srep00019 · Cited by 102
Cohen, A. D., Mowrey, W., Weissfeld, L. A., Aizenstein, H. J., McDade, E., Mountz, J. M., Nebes, R. D., Saxton, J. A., Snitz, B., DeKosky, S., et al. (2013) · NeuroImage · doi:10.1016/j.neuroimage.2013.01.015 · Cited by 97
In vivo assessment of amyloid‐β deposition in nondemented very elderly subjects
Mathis, C. A., Kuller, L. H., Klunk, W. E., Snitz, B. E., Price, J. C., Weissfeld, L. A., Rosario, B. L., Lopresti, B. J., Saxton, J. A., Aizenstein, H. J., et al. (2013) · Annals of Neurology · doi:10.1002/ana.23797 · Cited by 98
“Our findings that Ab deposition and its prevalence continue to increase with age are consistent with previous observations showing that AD pathology can be seen in a high proportion of autopsied NC subjects after age 80 years.(2,4,44) Bennett and colleagues reported that 66% of normal elderly subjects and 68% of those…”
BackgroundResultInfluentialRisk factors and global cognitive status related to brain arteriolosclerosis in elderly individuals
Ighodaro, E. T., Abner, E. L., Fardo, D. W., Lin, A.-L., Katsumata, Y., Schmitt, F. A., Kryscio, R. J., Jicha, G. A., Neltner, J. H., Monsell, S. E., et al. (2017) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x15621574 · Cited by 98
Diagnostic impact of CSF biomarkers for Alzheimer's disease in a tertiary memory clinic
Duits, F. H., Prins, N. D., Lemstra, A. W., Pijnenburg, Y. A. L., Bouwman, F. H., Teunissen, C. E., Scheltens, P., & van der Flier, W. M. (2015) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2014.05.1753 · Cited by 82
Advances in retina imaging as potential biomarkers for early diagnosis of Alzheimer’s disease
Zhang, Y., Wang, Y., Shi, C., Shen, M., & Lü, F. (2021) · Translational Neurodegeneration · doi:10.1186/s40035-021-00230-9 · Cited by 105
Seshadri, S., Beiser, A., Au, R., Wolf, P. A., Evans, D. A., Wilson, R. S., Petersen, R. C., Knopman, D. S., Rocca, W. A., Kawas, C. H., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2010.12.002 · Cited by 97
Long-Term Treatment with Citicoline May Improve Poststroke Vascular Cognitive Impairment
Alvarez-Sabín, J., Ortega, G., Jacas, C., Santamarina, E., Maisterra, O., Ribo, M., Molina, C., Quintana, M., & Román, G. C. (2013) · Cerebrovascular Diseases · doi:10.1159/000346602 · Cited by 96
Bell, S. M., Barnes, K., Clemmens, H., Al-Rafiah, A. R., Al-ofi, E. A., Leech, V., Bandmann, O., Shaw, P. J., Blackburn, D. J., Ferraiuolo, L., et al. (2018) · Journal of Molecular Biology · doi:10.1016/j.jmb.2018.08.019 · Cited by 97
Normative Cognitive Decline in Old Age
Wilson, R. S., Wang, T., Yu, L., Bennett, D. A., & Boyle, P. A. (2020) · Annals of Neurology · doi:10.1002/ana.25711 · Cited by 91
The influence of multimorbidity on clinical progression of dementia in a population-based cohort
Melis, R. J. F., Marengoni, A., Rizzuto, D., Teerenstra, S., Kivipelto, M., Angleman, S. B., & Fratiglioni, L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0084014 · Cited by 96
“This is in line with the model outlined by Fotuhi et al and other researchers who suggested a dynamic polygon hypothesis [27,28].”
Result
Metadata
- Authors
- Savva, G. M., Wharton, S. B., Ince, P. G., Forster, G., Matthews, F. E., & Brayne, C.
- Affiliations
- University of Cambridge (GB)
- University of Sheffield (GB)
- MRC Biostatistics Unit (GB)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2009-05-28
- Volume
- 360
- Issue
- 22
- Pages
- 2302-2309
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W1998088268
- Cited by
- 900
- References
- 34
- Citations by year
- 2026: 18 · 2025: 36 · 2024: 57 · 2023: 25 · 2022: 33 · 2021: 52 · 2020: 41 · 2019: 60 · 2018: 51 · 2017: 51 · 2016: 56 · 2015: 59 · 2014: 73 · 2013: 75 · 2012: 71
- FWCI
- 43.44
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Repository@Hull (Worktribe) (University of Hull) (submittedVersion, cc-by)
- Repository@Hull (Worktribe) (University of Hull) (submittedVersion)
- UEA Digital Repository (University of East Anglia) (submittedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Keywords
- Alzheimer's disease, dementia, neuropathology, age effects, cerebrovascular disease, neuritic plaques, brain donation, MRC Cognitive Function and Ageing Study
- MeSH terms
- Age Factors, Aged, Aged, 80 and over, Aging, Alzheimer Disease, Atrophy, Autopsy, Brain, Cerebrovascular Disorders, Dementia, Female, Humans, Male, Odds Ratio, Lewy Bodies, Plaque, Amyloid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.